X4 Pharmaceuticals secures up to $150 million senior debt facility with K2 HealthVentures to strengthen financial flexibility and support corporate activities.
Amount Raised
$80 Million
Round Type
Debt Financing
BostonBiotechnologyHealthcareInvestors
Description
X4 Pharmaceuticals has announced a senior secured term loan facility of up to $150 million with K2 HealthVentures. The first tranche of $80 million has funded to pay off prior obligations under an existing loan. The new facility aims to support corporate activities, including the future commercial launch of mavorixafor. This partnership enhances X4's financial position as it approaches key developmental milestones.
Quick answer
X4 Pharmaceuticals raised $80 Million in a Debt Financing round, dated October 8, 2026. Investors: Ankura Trust Company, LLC, K2 HealthVentures LLC and K2 HealthVentures. X4 Pharmaceuticals is based in Boston, Massachusetts, United States.
- How much did X4 Pharmaceuticals raise?
- X4 Pharmaceuticals raised $80 Million in a Debt Financing round on October 8, 2026.
- Who invested in X4 Pharmaceuticals?
- Ankura Trust Company, LLC, K2 HealthVentures LLC and K2 HealthVentures are named as investors in this round.
- What does X4 Pharmaceuticals do?
- X4 Pharmaceuticals is a fully integrated, commercial-stage biopharmaceutical company focused on driving progress for people living with rare immune disorders.
- Where is X4 Pharmaceuticals based and how big is it?
- X4 Pharmaceuticals is based in Boston, Massachusetts, United States. Fundz records about 111 employees.
- Who are the decision-makers at X4 Pharmaceuticals?
- Fundz holds 1 contact at X4 Pharmaceuticals, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as X4 Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Annovis Bio raised $21M (Post-IPO Equity) on November 5, 2026.
- Equinox raised $1B on November 2, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Araceli Biosciences raised $4.5M (Seed) on October 20, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
Who to call at X4 Pharmaceuticals, and when
A new round usually means X4 Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day X4 Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at X4 Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at X4 Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment X4 Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
X4 Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.